Evicenter
P&T meetings

Dersimelagon (MT-7117)

Erythropoietic protoporphyria or X-linked protoporphyria

Manufacturer
LEO Pharma
Regulatory submission
NDA submitted June 2026
Last updated
100 sources

Product information and disease descriptionProduct descriptionProduct information

American hospital formulary service (AHFS), or other drug classification

1 evidence topic · 1 source

American Hospital Formulary Service classification and WHO Anatomical Therapeutic Chemical code

No evidence found.

Drug class used as the cost analogue in the Dutch horizon scan

“Kosten op basis van IHSI-inschatting, afgeleid van de mediane kosten van dezelfde ATC-klasse (D02BB - systemisch werkende UV‑protectiva) geneesmiddelen in Nederland.” (opens the source at this quote in a new tab)